Caring Brands, Inc.
CABR Nasdaq Perfumes, Cosmetics & Other Toilet Preparations Financials FY2024–FY2025
Last close · Oct 23, 2026
$1.05
0.0%What Caring Brands, Inc. does
No business description yet.
- Legal name
- Caring Brands, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 31, 2026
- Accession · CIK
- 0001493152-26-013844
0002020737
Revenue and margins
Caring Brands, Inc. had $0.0M of revenue in fiscal 2025.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Caring Brands, Inc. returned — to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Caring Brands, Inc. can carry it.
| Fiscal year end | FY24 | FY25 |
|---|---|---|
| Cash and short-term investments | $0.5M | $2.2M |
| Debt incl. finance leases | — | $0.1M |
| Debt / equity | — | 0.0x |
| Interest coverage | — | −309.1x |
| Current ratio | 2.8x | 13.2x |
| Quick ratio | 2.8x | 13.1x |
| Total assets | $3.9M | $2.3M |
| Total liabilities | $0.2M | $0.2M |
| Shareholders' equity | $3.7M | $2.1M |
| Net debt (− = net cash) | — | −$2.1M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | ✕ | ✕ |
| Cash from operations is positive | — | ✕ |
| Return on assets rose | — | ✕ |
| Cash from operations exceeds net income | — | ✓ |
| Debt fell relative to assets | — | — |
| Current ratio rose | — | ✓ |
| Share count didn't rise | — | — |
| Gross margin rose | — | — |
| Revenue rose relative to assets | — | — |
| F-score | — / 1 | — / 5 |
| Accruals ratio | — | −147.8% |
| Altman Z'' | — | −11.76 |
2 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Income statement | ||
| Revenue | — | $0.0M |
| Net interest income | — | $0.0M |
| Gross profit | — | $0.0M |
| Research and development | $0.0M | $0.0M |
| Operating income | — | −$5.9M |
| Interest expense | — | $0.0M |
| Income tax | $0.0M | $0.0M |
| Net income | −$1.5M | −$6.3M |
| Diluted EPS | — | −$0.46 |
| Diluted shares | — | 0.01B |
| Cash flow | ||
| Cash from operations | — | −$1.7M |
| Depreciation and amortization | — | $0.3M |
| Stock-based compensation | — | $1.2M |
| Balance sheet | ||
| Cash and short-term investments | $0.5M | $2.2M |
| Total debt | — | $0.1M |
| Current assets | $0.5M | $2.3M |
| Current liabilities | $0.2M | $0.2M |
| Inventory | $0.0M | $0.0M |
| Intangible assets | $2.9M | $2.6M |
| Total assets | $3.9M | $2.3M |
| Total liabilities | $0.2M | $0.2M |
| Shareholders' equity | $3.7M | $2.1M |
| Margins | ||
| Gross margin | — | 54.8% |
| Operating margin | — | −141,309.5% |
| EBITDA margin | — | −134,166.7% |
| Net margin | — | −149,481.0% |
| Net interest share of revenue | — | 457.1% |
| Returns | ||
| Return on capital employed | — | −276.0% |
| Return on equity | −41.1% | −217.1% |
| Return on assets | −39.1% | −202.4% |
| Return on tangible equity | −180.3% | — |
| Financial health | ||
| Debt / equity | — | 0.0x |
| Interest coverage | — | −309.1x |
| Current ratio | 2.8x | 13.2x |
| Quick ratio | 2.8x | 13.1x |
| Capital allocation | ||
| Stock comp / revenue | — | 29,492.9% |
| Quality scores | ||
| Altman Z'' | — | −11.8 |
| Accruals ratio | — | −147.8% |
Source: SEC EDGAR XBRL filings (CIK 0002020737). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.